Neurological Disorder Drugs Market, Global Outlook and Forecast 2022-2028

April 2022 | 72 pages | ID: N0BA5DFE43BAEN
Market Monitor Global

Abstracts

Several government initiatives across various countries to educate masses about the rise of various diseases and increasing healthcare sector producing new drugs are the prime reasons for growth of neurological disorder drugs market. European Parkinson’s Disease Association, in Europe is actively supporting research and development by campaigning to raise awareness, and providing medication to patients is boosting the overall neurological disorder drugs market. This region is also witnessing rising focus on research and development programs that will help in producing affordable and effective drugs. The countries are collectively spending on developing neurological disorder drugs thus, improving the revenue of the market during the forecast period.

This report contains market size and forecasts of Neurological Disorder Drugs in global, including the following market information:

Global Neurological Disorder Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Neurological Disorder Drugs Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Neurological Disorder Drugs companies in 2021 (%)

The global Neurological Disorder Drugs market was valued at 19820 million in 2021 and is projected to reach US$ 25180 million by 2028, at a CAGR of 3.5% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Antipsychotic Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Neurological Disorder Drugs include Novartis, GlaxoSmithKline, Merck & Co., Bayer, AstraZeneca, Boehringer Ingelheim and Teva Pharmaceutical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Neurological Disorder Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Neurological Disorder Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Neurological Disorder Drugs Market Segment Percentages, by Type, 2021 (%)

• Antipsychotic
• Hypnotic & Sedative
• Analgesics
• Anticoagulants
• Others

Global Neurological Disorder Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Neurological Disorder Drugs Market Segment Percentages, by Application, 2021 (%)

• Hospital
• Clinic

Global Neurological Disorder Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Neurological Disorder Drugs Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Neurological Disorder Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Neurological Disorder Drugs revenues share in global market, 2021 (%)

Key companies Neurological Disorder Drugs sales in global market, 2017-2022 (Estimated), (K Units)

Key companies Neurological Disorder Drugs sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Novartis
• GlaxoSmithKline
• Merck & Co.
• Bayer
• AstraZeneca
• Boehringer Ingelheim
• Teva Pharmaceutical

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Neurological Disorder Drugs Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Neurological Disorder Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL NEUROLOGICAL DISORDER DRUGS OVERALL MARKET SIZE

2.1 Global Neurological Disorder Drugs Market Size: 2021 VS 2028
2.2 Global Neurological Disorder Drugs Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Neurological Disorder Drugs Sales: 2017-2028

3 COMPANY LANDSCAPE

3.1 Top Neurological Disorder Drugs Players in Global Market
3.2 Top Global Neurological Disorder Drugs Companies Ranked by Revenue
3.3 Global Neurological Disorder Drugs Revenue by Companies
3.4 Global Neurological Disorder Drugs Sales by Companies
3.5 Global Neurological Disorder Drugs Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Neurological Disorder Drugs Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Neurological Disorder Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Neurological Disorder Drugs Players in Global Market
  3.8.1 List of Global Tier 1 Neurological Disorder Drugs Companies
  3.8.2 List of Global Tier 2 and Tier 3 Neurological Disorder Drugs Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Neurological Disorder Drugs Market Size Markets, 2021 & 2028
  4.1.2 Antipsychotic
  4.1.3 Hypnotic & Sedative
  4.1.4 Analgesics
  4.1.5 Anticoagulants
  4.1.6 Others
4.2 By Type - Global Neurological Disorder Drugs Revenue & Forecasts
  4.2.1 By Type - Global Neurological Disorder Drugs Revenue, 2017-2022
  4.2.2 By Type - Global Neurological Disorder Drugs Revenue, 2023-2028
  4.2.3 By Type - Global Neurological Disorder Drugs Revenue Market Share, 2017-2028
4.3 By Type - Global Neurological Disorder Drugs Sales & Forecasts
  4.3.1 By Type - Global Neurological Disorder Drugs Sales, 2017-2022
  4.3.2 By Type - Global Neurological Disorder Drugs Sales, 2023-2028
  4.3.3 By Type - Global Neurological Disorder Drugs Sales Market Share, 2017-2028
4.4 By Type - Global Neurological Disorder Drugs Price (Manufacturers Selling Prices), 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Neurological Disorder Drugs Market Size, 2021 & 2028
  5.1.2 Hospital
  5.1.3 Clinic
5.2 By Application - Global Neurological Disorder Drugs Revenue & Forecasts
  5.2.1 By Application - Global Neurological Disorder Drugs Revenue, 2017-2022
  5.2.2 By Application - Global Neurological Disorder Drugs Revenue, 2023-2028
  5.2.3 By Application - Global Neurological Disorder Drugs Revenue Market Share, 2017-2028
5.3 By Application - Global Neurological Disorder Drugs Sales & Forecasts
  5.3.1 By Application - Global Neurological Disorder Drugs Sales, 2017-2022
  5.3.2 By Application - Global Neurological Disorder Drugs Sales, 2023-2028
  5.3.3 By Application - Global Neurological Disorder Drugs Sales Market Share, 2017-2028
5.4 By Application - Global Neurological Disorder Drugs Price (Manufacturers Selling Prices), 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Neurological Disorder Drugs Market Size, 2021 & 2028
6.2 By Region - Global Neurological Disorder Drugs Revenue & Forecasts
  6.2.1 By Region - Global Neurological Disorder Drugs Revenue, 2017-2022
  6.2.2 By Region - Global Neurological Disorder Drugs Revenue, 2023-2028
  6.2.3 By Region - Global Neurological Disorder Drugs Revenue Market Share, 2017-2028
6.3 By Region - Global Neurological Disorder Drugs Sales & Forecasts
  6.3.1 By Region - Global Neurological Disorder Drugs Sales, 2017-2022
  6.3.2 By Region - Global Neurological Disorder Drugs Sales, 2023-2028
  6.3.3 By Region - Global Neurological Disorder Drugs Sales Market Share, 2017-2028
6.4 North America
  6.4.1 By Country - North America Neurological Disorder Drugs Revenue, 2017-2028
  6.4.2 By Country - North America Neurological Disorder Drugs Sales, 2017-2028
  6.4.3 US Neurological Disorder Drugs Market Size, 2017-2028
  6.4.4 Canada Neurological Disorder Drugs Market Size, 2017-2028
  6.4.5 Mexico Neurological Disorder Drugs Market Size, 2017-2028
6.5 Europe
  6.5.1 By Country - Europe Neurological Disorder Drugs Revenue, 2017-2028
  6.5.2 By Country - Europe Neurological Disorder Drugs Sales, 2017-2028
  6.5.3 Germany Neurological Disorder Drugs Market Size, 2017-2028
  6.5.4 France Neurological Disorder Drugs Market Size, 2017-2028
  6.5.5 U.K. Neurological Disorder Drugs Market Size, 2017-2028
  6.5.6 Italy Neurological Disorder Drugs Market Size, 2017-2028
  6.5.7 Russia Neurological Disorder Drugs Market Size, 2017-2028
  6.5.8 Nordic Countries Neurological Disorder Drugs Market Size, 2017-2028
  6.5.9 Benelux Neurological Disorder Drugs Market Size, 2017-2028
6.6 Asia
  6.6.1 By Region - Asia Neurological Disorder Drugs Revenue, 2017-2028
  6.6.2 By Region - Asia Neurological Disorder Drugs Sales, 2017-2028
  6.6.3 China Neurological Disorder Drugs Market Size, 2017-2028
  6.6.4 Japan Neurological Disorder Drugs Market Size, 2017-2028
  6.6.5 South Korea Neurological Disorder Drugs Market Size, 2017-2028
  6.6.6 Southeast Asia Neurological Disorder Drugs Market Size, 2017-2028
  6.6.7 India Neurological Disorder Drugs Market Size, 2017-2028
6.7 South America
  6.7.1 By Country - South America Neurological Disorder Drugs Revenue, 2017-2028
  6.7.2 By Country - South America Neurological Disorder Drugs Sales, 2017-2028
  6.7.3 Brazil Neurological Disorder Drugs Market Size, 2017-2028
  6.7.4 Argentina Neurological Disorder Drugs Market Size, 2017-2028
6.8 Middle East & Africa
  6.8.1 By Country - Middle East & Africa Neurological Disorder Drugs Revenue, 2017-2028
  6.8.2 By Country - Middle East & Africa Neurological Disorder Drugs Sales, 2017-2028
  6.8.3 Turkey Neurological Disorder Drugs Market Size, 2017-2028
  6.8.4 Israel Neurological Disorder Drugs Market Size, 2017-2028
  6.8.5 Saudi Arabia Neurological Disorder Drugs Market Size, 2017-2028
  6.8.6 UAE Neurological Disorder Drugs Market Size, 2017-2028

7 MANUFACTURERS & BRANDS PROFILES

7.1 Novartis
  7.1.1 Novartis Corporate Summary
  7.1.2 Novartis Business Overview
  7.1.3 Novartis Neurological Disorder Drugs Major Product Offerings
  7.1.4 Novartis Neurological Disorder Drugs Sales and Revenue in Global (2017-2022)
  7.1.5 Novartis Key News
7.2 GlaxoSmithKline
  7.2.1 GlaxoSmithKline Corporate Summary
  7.2.2 GlaxoSmithKline Business Overview
  7.2.3 GlaxoSmithKline Neurological Disorder Drugs Major Product Offerings
  7.2.4 GlaxoSmithKline Neurological Disorder Drugs Sales and Revenue in Global (2017-2022)
  7.2.5 GlaxoSmithKline Key News
7.3 Merck & Co.
  7.3.1 Merck & Co. Corporate Summary
  7.3.2 Merck & Co. Business Overview
  7.3.3 Merck & Co. Neurological Disorder Drugs Major Product Offerings
  7.3.4 Merck & Co. Neurological Disorder Drugs Sales and Revenue in Global (2017-2022)
  7.3.5 Merck & Co. Key News
7.4 Bayer
  7.4.1 Bayer Corporate Summary
  7.4.2 Bayer Business Overview
  7.4.3 Bayer Neurological Disorder Drugs Major Product Offerings
  7.4.4 Bayer Neurological Disorder Drugs Sales and Revenue in Global (2017-2022)
  7.4.5 Bayer Key News
7.5 AstraZeneca
  7.5.1 AstraZeneca Corporate Summary
  7.5.2 AstraZeneca Business Overview
  7.5.3 AstraZeneca Neurological Disorder Drugs Major Product Offerings
  7.5.4 AstraZeneca Neurological Disorder Drugs Sales and Revenue in Global (2017-2022)
  7.5.5 AstraZeneca Key News
7.6 Boehringer Ingelheim
  7.6.1 Boehringer Ingelheim Corporate Summary
  7.6.2 Boehringer Ingelheim Business Overview
  7.6.3 Boehringer Ingelheim Neurological Disorder Drugs Major Product Offerings
  7.6.4 Boehringer Ingelheim Neurological Disorder Drugs Sales and Revenue in Global (2017-2022)
  7.6.5 Boehringer Ingelheim Key News
7.7 Teva Pharmaceutical
  7.7.1 Teva Pharmaceutical Corporate Summary
  7.7.2 Teva Pharmaceutical Business Overview
  7.7.3 Teva Pharmaceutical Neurological Disorder Drugs Major Product Offerings
  7.7.4 Teva Pharmaceutical Neurological Disorder Drugs Sales and Revenue in Global (2017-2022)
  7.7.5 Teva Pharmaceutical Key News

8 GLOBAL NEUROLOGICAL DISORDER DRUGS PRODUCTION CAPACITY, ANALYSIS

8.1 Global Neurological Disorder Drugs Production Capacity, 2017-2028
8.2 Neurological Disorder Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Neurological Disorder Drugs Production by Region

9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS

9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints

10 NEUROLOGICAL DISORDER DRUGS SUPPLY CHAIN ANALYSIS

10.1 Neurological Disorder Drugs Industry Value Chain
10.2 Neurological Disorder Drugs Upstream Market
10.3 Neurological Disorder Drugs Downstream and Clients
10.4 Marketing Channels Analysis
  10.4.1 Marketing Channels
  10.4.2 Neurological Disorder Drugs Distributors and Sales Agents in Global

11 CONCLUSION

12 APPENDIX

12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Key Players of Neurological Disorder Drugs in Global Market
Table 2. Top Neurological Disorder Drugs Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Neurological Disorder Drugs Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Neurological Disorder Drugs Revenue Share by Companies, 2017-2022
Table 5. Global Neurological Disorder Drugs Sales by Companies, (K Units), 2017-2022
Table 6. Global Neurological Disorder Drugs Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Neurological Disorder Drugs Price (2017-2022) & (USD/Unit)
Table 8. Global Manufacturers Neurological Disorder Drugs Product Type
Table 9. List of Global Tier 1 Neurological Disorder Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Neurological Disorder Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Neurological Disorder Drugs Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Neurological Disorder Drugs Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Neurological Disorder Drugs Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Neurological Disorder Drugs Sales (K Units), 2017-2022
Table 15. By Type - Global Neurological Disorder Drugs Sales (K Units), 2023-2028
Table 16. By Application – Global Neurological Disorder Drugs Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Neurological Disorder Drugs Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Neurological Disorder Drugs Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Neurological Disorder Drugs Sales (K Units), 2017-2022
Table 20. By Application - Global Neurological Disorder Drugs Sales (K Units), 2023-2028
Table 21. By Region – Global Neurological Disorder Drugs Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Neurological Disorder Drugs Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Neurological Disorder Drugs Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Neurological Disorder Drugs Sales (K Units), 2017-2022
Table 25. By Region - Global Neurological Disorder Drugs Sales (K Units), 2023-2028
Table 26. By Country - North America Neurological Disorder Drugs Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Neurological Disorder Drugs Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Neurological Disorder Drugs Sales, (K Units), 2017-2022
Table 29. By Country - North America Neurological Disorder Drugs Sales, (K Units), 2023-2028
Table 30. By Country - Europe Neurological Disorder Drugs Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Neurological Disorder Drugs Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Neurological Disorder Drugs Sales, (K Units), 2017-2022
Table 33. By Country - Europe Neurological Disorder Drugs Sales, (K Units), 2023-2028
Table 34. By Region - Asia Neurological Disorder Drugs Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Neurological Disorder Drugs Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Neurological Disorder Drugs Sales, (K Units), 2017-2022
Table 37. By Region - Asia Neurological Disorder Drugs Sales, (K Units), 2023-2028
Table 38. By Country - South America Neurological Disorder Drugs Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Neurological Disorder Drugs Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Neurological Disorder Drugs Sales, (K Units), 2017-2022
Table 41. By Country - South America Neurological Disorder Drugs Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Neurological Disorder Drugs Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Neurological Disorder Drugs Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Neurological Disorder Drugs Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Neurological Disorder Drugs Sales, (K Units), 2023-2028
Table 46. Novartis Corporate Summary
Table 47. Novartis Neurological Disorder Drugs Product Offerings
Table 48. Novartis Neurological Disorder Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 49. GlaxoSmithKline Corporate Summary
Table 50. GlaxoSmithKline Neurological Disorder Drugs Product Offerings
Table 51. GlaxoSmithKline Neurological Disorder Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 52. Merck & Co. Corporate Summary
Table 53. Merck & Co. Neurological Disorder Drugs Product Offerings
Table 54. Merck & Co. Neurological Disorder Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 55. Bayer Corporate Summary
Table 56. Bayer Neurological Disorder Drugs Product Offerings
Table 57. Bayer Neurological Disorder Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 58. AstraZeneca Corporate Summary
Table 59. AstraZeneca Neurological Disorder Drugs Product Offerings
Table 60. AstraZeneca Neurological Disorder Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 61. Boehringer Ingelheim Corporate Summary
Table 62. Boehringer Ingelheim Neurological Disorder Drugs Product Offerings
Table 63. Boehringer Ingelheim Neurological Disorder Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 64. Teva Pharmaceutical Corporate Summary
Table 65. Teva Pharmaceutical Neurological Disorder Drugs Product Offerings
Table 66. Teva Pharmaceutical Neurological Disorder Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 67. Neurological Disorder Drugs Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 68. Global Neurological Disorder Drugs Capacity Market Share of Key Manufacturers, 2020-2022
Table 69. Global Neurological Disorder Drugs Production by Region, 2017-2022 (K Units)
Table 70. Global Neurological Disorder Drugs Production by Region, 2023-2028 (K Units)
Table 71. Neurological Disorder Drugs Market Opportunities & Trends in Global Market
Table 72. Neurological Disorder Drugs Market Drivers in Global Market
Table 73. Neurological Disorder Drugs Market Restraints in Global Market
Table 74. Neurological Disorder Drugs Raw Materials
Table 75. Neurological Disorder Drugs Raw Materials Suppliers in Global Market
Table 76. Typical Neurological Disorder Drugs Downstream
Table 77. Neurological Disorder Drugs Downstream Clients in Global Market
Table 78. Neurological Disorder Drugs Distributors and Sales Agents in Global Market

List Of Figures

LIST OF FIGURES

Figure 1. Neurological Disorder Drugs Segment by Type
Figure 2. Neurological Disorder Drugs Segment by Application
Figure 3. Global Neurological Disorder Drugs Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Neurological Disorder Drugs Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Neurological Disorder Drugs Revenue, 2017-2028 (US$, Mn)
Figure 7. Neurological Disorder Drugs Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Neurological Disorder Drugs Revenue in 2021
Figure 9. By Type - Global Neurological Disorder Drugs Sales Market Share, 2017-2028
Figure 10. By Type - Global Neurological Disorder Drugs Revenue Market Share, 2017-2028
Figure 11. By Type - Global Neurological Disorder Drugs Price (USD/Unit), 2017-2028
Figure 12. By Application - Global Neurological Disorder Drugs Sales Market Share, 2017-2028
Figure 13. By Application - Global Neurological Disorder Drugs Revenue Market Share, 2017-2028
Figure 14. By Application - Global Neurological Disorder Drugs Price (USD/Unit), 2017-2028
Figure 15. By Region - Global Neurological Disorder Drugs Sales Market Share, 2017-2028
Figure 16. By Region - Global Neurological Disorder Drugs Revenue Market Share, 2017-2028
Figure 17. By Country - North America Neurological Disorder Drugs Revenue Market Share, 2017-2028
Figure 18. By Country - North America Neurological Disorder Drugs Sales Market Share, 2017-2028
Figure 19. US Neurological Disorder Drugs Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Neurological Disorder Drugs Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Neurological Disorder Drugs Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Neurological Disorder Drugs Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Neurological Disorder Drugs Sales Market Share, 2017-2028
Figure 24. Germany Neurological Disorder Drugs Revenue, (US$, Mn), 2017-2028
Figure 25. France Neurological Disorder Drugs Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Neurological Disorder Drugs Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Neurological Disorder Drugs Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Neurological Disorder Drugs Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Neurological Disorder Drugs Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Neurological Disorder Drugs Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Neurological Disorder Drugs Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Neurological Disorder Drugs Sales Market Share, 2017-2028
Figure 33. China Neurological Disorder Drugs Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Neurological Disorder Drugs Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Neurological Disorder Drugs Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Neurological Disorder Drugs Revenue, (US$, Mn), 2017-2028
Figure 37. India Neurological Disorder Drugs Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Neurological Disorder Drugs Revenue Market Share, 2017-2028
Figure 39. By Country - South America Neurological Disorder Drugs Sales Market Share, 2017-2028
Figure 40. Brazil Neurological Disorder Drugs Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Neurological Disorder Drugs Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Neurological Disorder Drugs Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Neurological Disorder Drugs Sales Market Share, 2017-2028
Figure 44. Turkey Neurological Disorder Drugs Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Neurological Disorder Drugs Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Neurological Disorder Drugs Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Neurological Disorder Drugs Revenue, (US$, Mn), 2017-2028
Figure 48. Global Neurological Disorder Drugs Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Neurological Disorder Drugs by Region, 2021 VS 2028
Figure 50. Neurological Disorder Drugs Industry Value Chain
Figure 51. Marketing Channels